Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

Theodore R Pak; Chanu Rhee; Rui Wang; Michael Klompas

doi:10.1001/jamainternmed.2023.1261

Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

JAMA Intern Med. 2023 Aug 1;183(8):877-880. doi: 10.1001/jamainternmed.2023.1261.

Authors

Theodore R Pak¹, Chanu Rhee¹, Rui Wang¹, Michael Klompas¹

Affiliation

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, Massachusetts.

PMID: 37273229
PMCID: PMC10242507 (available on 2024-06-05)
DOI: 10.1001/jamainternmed.2023.1261

No abstract available

Plain language summary

This quality improvement study examines the association between the discontinuation of universal admission testing for SARS-CoV-2 infections and hospital-onset SARS-CoV-2 infections in England and Scotland.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19 Testing
COVID-19* / diagnosis
COVID-19* / epidemiology
England / epidemiology
Hospitals
Humans
SARS-CoV-2

Grants and funding

T32 AI007061/AI/NIAID NIH HHS/United States